Background: The authors aimed to conduct an extensive literature review and consensus meeting to identify unmet needs in ulcerative colitis (UC) and ways to overcome them. UC is a relapsing and remitting inflammatory bowel disease with varied, and changing, incidence rates worldwide. UC has an unpredictable disease course and is associated with a high health economic burden. During 2016 and 2017, a panel of experts was convened to identify, discuss and address areas of unmet need in UC. Methods: PubMed and Cochrane Library databases were searched for relevant articles describing studies performed in patients with UC. These findings were used to generate a set of statements relating to unmet needs in UC. Consensus on these statements was the...
BACKGROUND AND AIMS: Treatment of ulcerative colitis (UC) requires a patient-centric, definition of ...
Background and Aims: A “treat‐to‐target” approach has been proposed for ulcerative colitis (UC), wit...
Background: Ulcerative colitis (UC) is a chronic disease with a wide variety of treatment options ma...
BACKGROUND The authors aimed to conduct an extensive literature review and consensus meeting to ide...
BACKGROUND The authors aimed to conduct an extensive literature review and consensus meeting to ide...
Introduction: Ulcerative colitis (UC) by definition is an inflammation of the mucosa of the colon, i...
Background. The lifelong and remitting nature of ulcerative colitis results in considerable disabili...
Background. The lifelong and remitting nature of ulcerative colitis results in considerable disabili...
hese recommendations summarise the current evidence on the medical management of adult p...
Background and aims: Infliximab is currently the only biologic approved for treatment of adults with...
hese recommendations summarise the current evidence on the medical management of adult p...
Background and aims: Infliximab is currently the only biologic approved for treatment of adults with...
The objective of this study was to evaluate the consensus of expert societies and published guidelin...
BACKGROUND AND AIMS: Treatment of ulcerative colitis (UC) requires a patient-centric, definition of ...
BACKGROUND AND AIMS: Infliximab is currently the only biologic approved for treatment of adults wi...
BACKGROUND AND AIMS: Treatment of ulcerative colitis (UC) requires a patient-centric, definition of ...
Background and Aims: A “treat‐to‐target” approach has been proposed for ulcerative colitis (UC), wit...
Background: Ulcerative colitis (UC) is a chronic disease with a wide variety of treatment options ma...
BACKGROUND The authors aimed to conduct an extensive literature review and consensus meeting to ide...
BACKGROUND The authors aimed to conduct an extensive literature review and consensus meeting to ide...
Introduction: Ulcerative colitis (UC) by definition is an inflammation of the mucosa of the colon, i...
Background. The lifelong and remitting nature of ulcerative colitis results in considerable disabili...
Background. The lifelong and remitting nature of ulcerative colitis results in considerable disabili...
hese recommendations summarise the current evidence on the medical management of adult p...
Background and aims: Infliximab is currently the only biologic approved for treatment of adults with...
hese recommendations summarise the current evidence on the medical management of adult p...
Background and aims: Infliximab is currently the only biologic approved for treatment of adults with...
The objective of this study was to evaluate the consensus of expert societies and published guidelin...
BACKGROUND AND AIMS: Treatment of ulcerative colitis (UC) requires a patient-centric, definition of ...
BACKGROUND AND AIMS: Infliximab is currently the only biologic approved for treatment of adults wi...
BACKGROUND AND AIMS: Treatment of ulcerative colitis (UC) requires a patient-centric, definition of ...
Background and Aims: A “treat‐to‐target” approach has been proposed for ulcerative colitis (UC), wit...
Background: Ulcerative colitis (UC) is a chronic disease with a wide variety of treatment options ma...